It has been found that a strong expression of TNFR2 on regulatory T cells (Tregs) in ovarian cancer tissue creates a potent immunosuppressive tumour microenvironment and is associated with poor clinical response [127]. The gene discussed is TNFRSF1B; the disease is ovarian carcinoma.